← Leaderboards
Nicole Corbin-Stein
University Of Alabama At Birmingham
$212,364
Attributed
$212,364
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $86.2K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$212,364 · 2
By mechanism
K00$172,380 · 1
F99$39,984 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Roger B Fillingim$35,218,319
- Cora E Lewis$68,480,281
- Alan Kenneth Percy$11,873,575
- Thomas W Buford$9,083,841
- Marcas M Bamman$14,046,973
Others in their field
Other Rising Stars on “Cytoplasmic Inclusion”
- Zhihua Feng · Acurastem, Inc.$2,782,758
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$1,745,668
- Zachary Thomas McEachin · Emory University$1,283,766
- Jimena Giudice · University Of North Carolina At Chapel Hill$680,000
- Qinwen Mao · Utah State Higher Education System--University Of Utah$669,638
- Andrew Cal · Olipha Inc$293,629
Research focus
Cytoplasmic InclusionAdeno-Associated Viral VectorAdaptive Immune ResponseAgingAgreementAlpha SynucleinAlzheimer&AposAntigen PresentationAntigen-Presenting CellsAttenuatedAutopsyBehaviorBindingBioinformaticsCd3 AntigensCd4 Positive T LymphocytesCd8b1 GeneCell AgingCellsCerebral AtrophyCorpus CallosumCorpus Striatum StructureCytokineDefect
Grant awards (3)
Interferon-gamma mediates neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy (MSA)$86,190
K00 · FY2025 · NS · contact PI
Interferon-gamma mediates neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy (MSA)$86,190
K00 · FY2024 · NS · contact PI
Interferon-gamma mediates neuroinflammation, demyelination, and neurodegeneration in a mouse model of multiple system atrophy (MSA)$39,984
F99 · FY2023 · NS · contact PI